Details werden geladen...
Proteomic subtypes of AD: What do they mean and how will they influence or benefit drug development for Alzheimer's Disease: Charité – Universitätsmedizin Berlin
Veranstaltung der Charité – Universitätsmedizin Berlin
Ähnliche Seiten
Institute of Clinical Pharmacology and Toxicology - Charité – Universitätsmedizin Berlin
https://kliphatox.charite.de/en/s/pages/?amp=&cHash=68b1edb90b3479b21c25ee6dd275b506
Department of Gastroenterology, Infectious Diseases and Rheumatology (including Clinical Nutrition) - Charité – Universitätsmedizin Berlin
https://gastro.charite.de/en/
Department of Hepatology and Gastroenterology - Charité – Universitätsmedizin Berlin
https://hepatologie-gastroenterologie.charite.de/en/?adb_sid=86aa1685-b1b8-4b7e-be19-40dcb43744a8&=&cHash=94989201f4309c0be380d31c75971b40Department of Hepatology and Gastroenterology - Charité – Universitätsmedizin Berlin
https://hepatologie-gastroenterologie.charite.de/en/?amp=&ved=2ahUKEwibrZuKksGVAxWcR_EDHQ16DIkQgU96BAhfEAc&cHash=12fbe3363ad7dae20e50f8fc837164dd
Collaborative Research Centre TRR 265: Losing and Regaining Control over Drug Intake - Charité – Universitätsmedizin Berlin
https://sfb-trr265.charite.de/en/?amp=&rest_route=%2Fbatch%2Fv1&cHash=679b9d9659d3ccad6676c5ca5a9ea061